Patent 7629345 was granted and assigned to NicOx on December, 2009 by the United States Patent and Trademark Office.
Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.